DaJiMed supplies CE and ISO 13485 certified leukocyte reduction filter sets to blood bag manufacturers, blood banks, blood centers, hospital distributors, and major hospitals worldwide. Our filter sets achieve a leukocyte removal rate of over 99.9999% (≥6 log reduction), supporting the safe processing of whole blood (WB), red blood cells (RBC), and platelets (PLT). Whether you require a bedside-type or laboratory-type configuration, DaJiMed offers flexible OEM supply with customizable specifications to meet your procurement requirements.
Trusted by partners in 30+ countries · CE marked · ISO 13485 certified
At DaJiMed, we are dedicated to providing advanced leukoreduction filter sets that enhance the quality and safety of blood products. Our filter sets are designed to efficiently remove white blood cells from whole blood (WB), red blood cells (RBC), and platelets (PLT), catering to the needs of blood bag manufacturers, blood banks, blood centers, hospital distributors, and major hospitals.
Leukocyte reduction — also referred to as leukoreduction, leukodepletion, leucoreduction, or leukocyte removal — is the process of removing white blood cells (leukocytes) from donated blood components before transfusion or further processing. This step significantly reduces the risk of febrile non-hemolytic transfusion reactions (FNHTRs), cytomegalovirus (CMV) transmission, HLA alloimmunization, and other transfusion-related complications.
A leukocyte reduction filter set (also called a leukodepletion filter set or leucoreduction filter set) is the primary device used to achieve this process in both laboratory and bedside settings. DaJiMed's filter sets are engineered to meet the stringent requirements of modern blood banking and transfusion medicine.
DaJiMed's leukocyte reduction filter set is a complete, ready-to-use solution for leukocyte removal from whole blood (WB), red blood cells (RBC), and platelets (PLT). Each set integrates a high-performance filtration membrane with a transparent housing for real-time monitoring of the filtration process. The system is designed for seamless integration into existing blood processing workflows with minimal adaptation required.
All filter sets are manufactured in our GMP-certified facility under strict quality control procedures, using biocompatible materials compliant with ISO 10993 standards for blood-contacting devices.
| Specification | Whole Blood (WB) | Red Blood Cells (RBC) | Platelets (PLT) |
|---|---|---|---|
| Leukocyte removal rate | ≥99.9999% (6-log) | ≥99.9999% (6-log) | ≥99.9999% (6-log) |
| RBC / PLT recovery rate | ≥85% | ≥85% | ≥85% |
| Processing volume | Up to 450 ml | Up to 450 ml | Up to 600 ml |
| Filter type available | Bedside / Lab | Bedside / Lab | Bedside / Lab |
| Sterile packaging | Yes (EO sterilized) | Yes (EO sterilized) | Yes (EO sterilized) |
| Shelf life | 2 years | 2 years | 2 years |
| Certification | CE, ISO 13485 | CE, ISO 13485 | CE, ISO 13485 |
For detailed technical datasheets or custom specification requirements, please contact our sales team.
Efficient leukocyte removalAchieves ≥99.9999% leukocyte removal (≥6 log reduction), consistently meeting the clinical standards required by blood banks, hospitals, and regulatory bodies in EU, Asia, Latin America, and beyond.
High blood component recoveryMaintains a recovery rate of ≥85% for red blood cells and platelets, minimizing product loss and maximizing the clinical utility of each blood unit processed.
Transparent filter housingThe clear housing design allows operators to monitor filtration progress in real time, enabling quality checks without interrupting the process.
Biocompatible, blood-safe materialsAll blood-contacting materials are tested and certified to ISO 10993 standards, ensuring safety and compatibility with human blood components.
Easy integration into existing systemsFilter sets are designed with standard connection fittings compatible with major blood bag systems on the market, reducing workflow disruption for blood bag manufacturers and blood centers.
Available in bedside and laboratory configurationsBoth configurations support flexible deployment — bedside types for direct clinical use at point-of-transfusion, laboratory types for pre-storage leukodepletion during blood component processing.
Pre-storage leukodepletion and leukocyte reduction of whole blood, red blood cell concentrates, and platelet concentrates. Our advanced leukoreduction filter technology supports compliance with national and international blood safety standards while ensuring efficient leukocyte removal and consistent blood component quality.
Bedside leukocyte removal for patients requiring leukodepleted blood products, including immunocompromised patients, neonates, patients undergoing repeated transfusions, and organ transplant recipients.
Designed for large-scale blood collection programs, our filter sets provide reliable leukocyte reduction and leukodepletion during blood processing, helping organizations deliver safer blood products while maintaining operational efficiency.
Supports efficient leukocyte removal and leukocyte depletion during plasma processing workflows. The system helps reduce residual white blood cells and improves plasma quality for further medical and biopharmaceutical applications.
Our leukoreduction solutions contribute to high-quality source plasma preparation through effective leukocyte reduction, helping manufacturers achieve greater process consistency and compliance with GMP-driven production standards.
DaJiMed leukoreduction filter sets are widely applicable to national blood service programs and public healthcare systems. Complete regulatory documentation and performance validation data are available to demonstrate efficient leukocyte removal, leukocyte depletion, and blood safety compliance.
A comprehensive product portfolio for distributors seeking reliable leukocyte reduction filters, leukodepletion filters, and blood processing consumables. We support distributors with technical documentation, regulatory compliance materials, and long-term supply capabilities.
DaJiMed offers leukocyte reduction filter sets in three main categories, each available in bedside and laboratory configurations:
For Red Blood Cells (RBC)Optimized for leukodepletion of red blood cell concentrates. Available in bedside type (post-storage filtration at point of use) and laboratory type (pre-storage filtration during blood component processing).
For Whole Blood (WB)Designed for leukocyte removal from whole blood prior to component separation. Particularly suited for blood centers processing high volumes of donations.
For Platelets (PLT)Engineered to achieve high leukocyte removal efficiency while maintaining platelet recovery and function. Includes standard single-unit and octopus-type pooling kit configurations for multi-unit platelet pools.
View detailed product pages for full specifications, product codes, and ordering information.
DaJiMed is committed to the highest standards of product quality and regulatory compliance.
CE MarkingAll leukocyte reduction filter sets carry CE marking, confirming conformity with the EU Medical Device Regulation (MDR) requirements for safety and performance.
ISO 13485 CertificationOur quality management system is certified to ISO 13485, the international standard for medical device manufacturers. This ensures consistent product quality from raw material sourcing through to finished product release.
GMP ManufacturingProducts are manufactured in our GMP-compliant facility in Guangzhou, China, equipped with cleanroom production environments and automated quality inspection systems.
ISO 10993 BiocompatibilityAll blood-contacting materials undergo ISO 10993 biocompatibility testing to ensure patient safety.
Full certification documentation, product test reports, and regulatory dossiers are available to qualified buyers upon request. We support customers in meeting the import registration and tender documentation requirements of their local markets.
Specialized in leukocyte filtrationDaJiMed focuses exclusively on leukocyte reduction technology for blood processing. Our R&D, manufacturing, and quality systems are built around this single product category — giving us deeper technical expertise than generalist suppliers.
Global supply experienceOur leukocyte reduction filter sets and leukodepletion systems are supplied to customers across Europe, Southeast Asia, the Middle East, Latin America, and Africa. We understand the regulatory and logistics requirements of international medical device procurement.
Responsive technical supportOur team provides pre-sale technical consultation, product samples for evaluation, and after-sale support for product integration and quality queries.
Competitive pricing with reliable lead timesWe offer transparent pricing with volume-based options. Standard lead times are confirmed at the time of order, with expedited production available for urgent requirements.
Whether you are sourcing leukocyte reduction filter sets for a blood bank, evaluating leukodepletion solutions for OEM integration, or preparing documentation for a government tender, our team is ready to assist.
Tell us about your application and we will respond within one business day.
[Inquiry form — as currently on site, with business type selector: blood bag manufacturer / hospital / blood bank / government tender / medical distributor]
What is the difference between leukoreduction, leukodepletion, and leukocyte removal?
These three terms — leukoreduction, leukodepletion, leucoreduction, and leukocyte removal — all refer to the same process: the removal of white blood cells from blood products. The terminology varies by region and clinical context, but the underlying technology and clinical purpose are identical. DaJiMed's filter sets are designed to address all of these applications.
What types of blood components can DaJiMed's filter sets process?
Our leukocyte reduction filter sets are available for whole blood (WB), red blood cells (RBC), and platelets (PLT). Each product line is optimized for the specific viscosity, flow characteristics, and recovery requirements of each blood component type.
What is the leukocyte removal efficiency of DaJiMed filter sets?
DaJiMed filter sets achieve a leukocyte removal rate of ≥99.9999%, equivalent to ≥6 log reduction. This meets or exceeds the standards set by major blood banking authorities including the Council of Europe guidelines and AABB standards.
What is the difference between bedside type and laboratory type filters?
Bedside-type leukocyte reduction filters are used at the point of transfusion, filtering the blood immediately before it reaches the patient. Laboratory-type (or lab-type) filters are used during blood component processing in the blood bank, allowing pre-storage leukodepletion before the product is stored or distributed. Both types achieve equivalent leukocyte removal performance; the choice depends on your workflow and clinical protocol.
What certifications do DaJiMed leukocyte reduction filters carry?
Our products are CE marked and manufactured under an ISO 13485 certified quality management system. Blood-contacting materials are tested to ISO 10993 biocompatibility standards. Full documentation is available to qualified buyers.
What is the minimum order quantity (MOQ)?
MOQ varies by product type and configuration. Please contact our sales team with your specific requirements and we will provide a tailored quotation. We accommodate both small evaluation orders and large-volume supply contracts.
Can DaJiMed support government tender applications?
Yes. We have experience supplying to government hospital networks and public health procurement processes. We can provide all required regulatory documents, certificates, product test reports, and factory audit support for tender submissions.
No. 132 Buling Road, Huangpu District, Guangzhou, P.R.China
Copyright © Guangzhou DaJi Medical Science and Technology Co., Ltd. All Rights Reserved Sitemap | Powered by 
